LUIS
FONTANA GALLEGO
CATEDRÁTICO DE UNIVERSIDAD
Instituto de Salud Carlos III
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Instituto de Salud Carlos III (8)
2021
2019
-
Association of breast and gut microbiota dysbiosis and the risk of breast cancer: A case-control clinical study
BMC Cancer, Vol. 19, Núm. 1
-
Lactobacillus reuteri v3401 reduces inflammatory biomarkers and modifies the gastrointestinal microbiome in adults with metabolic syndrome: The PROSIR study
Nutrients, Vol. 11, Núm. 8
2018
-
Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: A randomized clinical trial (PROSIR)
BMC Complementary and Alternative Medicine, Vol. 18, Núm. 1
-
Human milk oligosaccharides and immune system development
Nutrients, Vol. 10, Núm. 8
2017
-
Adamdec1, Ednrb and Ptgs1/Cox1, inflammation genes upregulated in the intestinal mucosa of obese rats, are downregulated by three probiotic strains
Scientific Reports, Vol. 7, Núm. 1
-
Gene expression profiling in the intestinal mucosa of obese rats administered probiotic bacteria
Scientific Data, Vol. 4